Determinants of geographic variations in implantation of cardiac defibrillators in the European Society of Cardiology member countriesdata from the European Heart Rhythm Association White Book

Europace

Volumn 13, Issue 5, 2011, Pages 654-662

  Lubinski, Andrzej ^a   Bissinger, Andrzej ^a   Boersma, Lucas ^b   Leenhardt, Antoine ^c   Merkely, Bela ^d   Oto, Ali ^e   Proclemer, Alessandro ^f   Brugada, Josep ^g   Vardas, Panos E ^h   Wolpert, Christian ⁱ  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b ST ANTONIUS HOSPITAL   (Netherlands)

^c HÔPITAL LARIBOISIÈRE   (France)

^d SEMMELWEIS UNIVERSITY   (Hungary)

^e HACETTEPE UNIVERSITY   (Turkey)

^f SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^g UNIVERSITY OF BARCELONA   (Spain)

^h UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

ⁱ KLINIKUM LUDWIGSBURG   (Germany)

Author keywords

Europe; Geographic variations; Healthcare expenses; Implantable cardioverter defibrillator; Implantation rate; Reimbursement

Indexed keywords

ARTICLE; DEFIBRILLATOR; DEMOGRAPHY; HEALTH CARE COST; HEART RHYTHM; LIFE EXPECTANCY; MEDICAL SOCIETY; PRIORITY JOURNAL; REIMBURSEMENT;

ARRHYTHMIAS, CARDIAC; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; EUROPE; GEOGRAPHY; HEALTH CARE COSTS; HUMANS; REIMBURSEMENT MECHANISMS;

EID: 79955375472     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eur066     Document Type: Article

References (28)

1. Centers for Disease Control and Prevention. State-specific mortality from sudden cardiac death-United States, 1999. Morb Mortal Wkly Rep (MMWR) 2002;51: 123-6.
2. American Heart Association. 2002 Heart and Stroke Statistical. Dallas, TX: Amercian Heart Association 2001.
3. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999;341:1882-90.
4. Kuck KH, Cappato R, Siebels J, Ruppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 2000;102:748-54. (Pubitemid 30648765)
5. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83. (Pubitemid 34984635)
6. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004;350:2151-8. (Pubitemid 38637995)
7. Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. Eur Heart J 2000;21:2071-8.
8. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M et al. ACC/ AHA/ESC 2006 Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006;114:e385-484.
9. The EHRA White Book. July 2008. http://www.escardio.org/communities/EHRA/ publications/Documents/ehra-white-book-2008.pdf. 2010.
10. The EHRA White Book. July 2009. http://www.escardio.org/communities/EHRA/ publications/Documents/ehra-white-book-2009.pdf. 2010.
11. Merkely B, Roka A, Kutyifa V, Boersma L, Leenhardt A, Lubinski A et al. Tracing the European course of cardiac resynchronization therapy from 2006 to 2008. Europace 2010;12:692-701.
12. Mond HG, Irwin M, Ector H, Proclemer A. The world survey of cardiac pacing and cardioverter-defibrillators: calendar year 2005 an International Cardiac Pacing and Electrophysiology Society (ICPES) project. Pacing Clin Electrophysiol 2008;31: 1202-12.
13. Maisel WH. Pacemaker and ICD generator reliability: meta-analysis of device registries. JAMA 2006;295:1929-34.
14. Brown DW, Croft JB, Greenlund KJ, Mensah GA, Giles WH. Trends in hospitalization for the implantation of cardioverter-defibrillators in the United States, 1990-2005. Am J Cardiol 2008;101:1753-5.
15. Almendral J, Arribas F, Wolpert C, Ricci R, Adragao P, Cobo E et al. Dualchamber defibrillators reduce clinically significant adverse events compared with single-chamber devices: results from the DATAS (Dual chamber and Atrial Tachyarrhythmias Adverse events Study) trial. Europace 2008;10:528-35. (Pubitemid 351775295)
16. Ovsyshcher IE, Furman S. Determinants of geographic variations in pacemakers and implantable cardioverter defibrillators implantation rates. Pacing Clin Electrophysiol 2003;26:474-8. (Pubitemid 36399198)
17. Mark DB, Nelson CL, Anstrom KJ, Al Khatib SM, Tsiatis AA, Cowper PA et al. Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Circulation 2006;114:135-42. (Pubitemid 44420745)
18. Sanders GD, Hlatky MA, Owens DK. Cost-effectiveness of implantable cardioverter-defibrillators. N Engl J Med 2005;353:1471-80. (Pubitemid 41400921)
19. Cowie MR, Marshall D, Drummond M, Ferko N, Maschio M, Ekman M et al. Lifetime cost-effectiveness of prophylactic implantation of a cardioverter defibrillator in patients with reduced left ventricular systolic function: results of Markov modelling in a European population. Europace 2009;11:716-26.
20. Meine M, Smith T, Hauer RN. The economical challenge in the treatment of chronic heart failure: is primary prophylactic ICD therapy cost-effective in Europe? Europace 2009;11:689-91.
21. Heart Rhythm Devices: UK National Survey 2007. http://www.ccad.org.uk/ device. nsf. 2009.
22. Danish Pacemaker and ICD Register. http://www.pacemaker.dk. 2009.
23. Camm JA, Nisam S. European utilization of the implantable defibrillator: has 10 years changed the 'enigma'? Europace 2010;12:1063-9.
24. Sullivan A, Sheffrin SM. Economics: Principles in action. Upper Saddle River, New Jersey: Pearson Prentice Hall; 2003.
25. Merino JL, Arribas F, Botto GL, Huikuri H, Kraemer LI, Linde C et al. Core curriculum for the heart rhythm specialist. Europace 2009;11(Suppl. 3): iii1-26.
26. EUCOMED. Awareness of Device Therapy Survey, Brussels, December 2006.
27. Proclemer A, Ghidina M, Gregori D, Facchin D, Rebellato L, Fioretti P et al. Impact of the main implantable cardioverter-defibrillator trials in clinical practice: data from the Italian ICD Registry for the years 2005-07. Europace 2009;11: 465-75.
28. Greenberg SM, Epstein AE, Deering T, Goldman DS, Ghidina M, Neason C et al. A Comparison of ICD implantations in the United States versus Italy. Pacing Clin Electrophysiol 2007;30(Suppl. 1):S143-6. (Pubitemid 46121829)